Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2004, p. 2771-2773, Vol. 42, No. 6
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.6.2771-2773.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Virology, Institute of Medical Microbiology and Hygiene, University of Freiburg, 79008 Freiburg,1 Zentrum der Inneren Medizin, Medizinische Klinik III/Infektiologie, 60590 Frankfurt am Main, Germany,3 Departamento de Microbiologia, Instituto de Ciências Biomédicas Universidade de São Paulo, 05508-000 São Paulo, Brazil2
Received 16 January 2004/ Returned for modification 18 February 2004/ Accepted 16 March 2004
A Taqman amplicon targeting the nucleocapsid gene of severe acute respiratory syndrome coronavirus (SARS-CoV) is 5 log10 times more sensitive for SARS-CoV target RNA extracted from infected cells and 2.79 log10 times more sensitive for RNA extracted from patient material of the index case in Frankfurt than an amplicon targeting the polymerase gene.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»